TX HHS Form 1337. CHIP Drug Rebate Agreement

The TX HHS Form 1337, CHIP Drug Rebate Agreement, is a crucial document that helps solve the problem of establishing rebates for prescription outpatient drugs utilized by Children's Health Insurance Program (CHIP) recipients. This form is typically used in situations where manufacturers or labelers need to agree on rebate rates with the Texas Health and Human Services Commission (HHSC). The form is usually filled out by representatives from the manufacturer/labeler side.

This agreement outlines key features, including definitions of terms such as Average Manufacturer Price (AMP), Basic Rebate, Best Price, and Consumer Price Index-Urban Factor (CPI-U Factor). It also specifies responsibilities, such as the calculation of rebates using a specific methodology. The form requires information on covered outpatient drugs, innovator multiple source drugs, and average prices paid to manufacturers by wholesalers.

The CHIP Drug Rebate Agreement is an essential tool for ensuring that CHIP recipients receive fair and reasonable rebates for prescription outpatient drugs. Key points to note include:

• Establishes rebate rates for single-source drugs and innovator multiple source drugs
• Requires information on covered outpatient drugs and innovator multiple source drugs
• Calculates rebates using a specific methodology
• Specifies responsibilities for manufacturers/labelers and HHSC